Have you heard about the new gene discovered that's implicated in the cause of Type 2 diabetes?
Scientists at Joslin Diabetes Center used lab mice to show that alterations in a gene called ARNT (aryl hydrocarbon receptor nuclear translocator) -- which is crucial for normal embryo development, and also controls other genes -- correlates closely with incidence of Type 2 diabetes.
What this means is that the ARNT gene may be pivotal in generating (and hopefully curing) Type 2 diabetes.
"ARNT is the first gene identified to be abnormal in the pancreatic islet cells, the cells that make insulin, in people with the common type of Type 2 diabetes," said study leader Dr. C. Ronald Kahn.
Dr. Robert Rizza, president of the American Diabetes Association, said: "It's very likely this disease is not going to be caused by a single gene. The common type of diabetes seems to be caused by multiple genes interacting."
But Rizza adds: "It's a very important finding. By altering one or two genes that play a role in the development of diabetes, you may be able to cure it."
Hope springs eternal. Read the whole story HERE.
Can you focus an entire diabetes innovation event on Quality of Life? Yes, you can! In fact, it's the stuff that builds the foundation for the ever-elusive "improved health outcomes" we're all after. This was the premise behind the sixth annual...
Momentum seems to be building big time around the outrage over skyrocketing insulin prices, which are making this life-sustaining drug virtually unavailable to those who need it.In just the past several weeks, we've seen:Mainstream media coverag...
Happy Saturday! Welcome to Ask D'Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois.This week, Wil offers some thought on rapidly changing blood sugars when insulin's on board, and how that ...
Welcome back to our weekly diabetes advice column, Ask D'Mine - with your host veteran type 1, diabetes author and educator Wil Dubois. This week, Wil's addressing the sometimes unavoidable issue of wasting precious insulin, something that pains ...
We reported earlier this week about a landmark roundtable gathering of diabetes advocates and industry leaders in Washington D.C. to address the complex problem of insulin affordability and access here in the U.S. Coordinated by the National Diab...